Three of the most deadly cancers get critical funding for research
(Alliance for Cancer Gene Therapy) Three of the most deadly cancers -- glioblastoma, sarcoma and ovarian -- get critical funding for clinical trials from Alliance for Cancer Gene Therapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Funding | Gene Therapy | Genetics | Ovarian Cancer | Ovaries | Sarcomas